Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma

This study has been withdrawn prior to enrollment.
(Withdrawn in October 2006, no longer of interest)
Sponsor:
Information provided by (Responsible Party):
Thomas Olencki, Ohio State University Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT00293527
First received: February 15, 2006
Last updated: May 22, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: November 2006
  Estimated Primary Completion Date: No date given